Arşiv logosu
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • Sistem İçeriği
  • Analiz
  • Talep/Soru
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Unver, Tuba" seçeneğine göre listele

Listeleniyor 1 - 7 / 7
Sayfa Başına Sonuç
Sıralama seçenekleri
  • Küçük Resim Yok
    Öğe
    Anti-infective effect of Aquilaria malaccensis L. essential oil against Candida strains, the leading cause of yeast infectious
    (2025) Unver, Tuba; ERENLER, SEBNEM; KIRAN, TUGBA RAIKA
    Aquilaria malaccensis L., known as Agarwood, is widely found in India, Malaysia, Bhutan, and Indonesia. It is a pleasantly scented plant used in the production of resin. It is an interesting material in the field of health due to its resin and essential oil, which exhibit antimicrobial properties. This study aimed to evaluate the antifungal properties of A. malaccensis L. essential oil and determine its minimum inhibitory concentrations (MIC) against the Candida species tested. The inhibitory effect of A. malaccensis L. essential oil was tested on five Candida species. The broth microdilution method was used to determine the MIC values against the tested microorganisms, and the viability of microorganisms exposed to the plant essential oil was assessed using resazurin sodium salt. According to the results, the MIC of the plant essential oil against Candida tropicalis, Candida krusei and Candida albicans is 62.50 µL/mL. While the MIC against Candida glabrata is 31.25 µL/mL, the MIC against Candida parapsilosis is 7.81 µL/mL. These results show the potential of A. malaccensis L. as an anti-candidal agent. The continuation of this study revealed the need for optimizing and implementing more comprehensive antimicrobial tests.
  • Küçük Resim Yok
    Öğe
    Assessment of the Antifungal Effect of Biotechnological Product-A New Vegan Agent Microbial Chondroitin Sulfate Against Predominant Candida Strains
    (Jihad Daneshgahi, 2024) Erenler, Ayse Sebnem; Unver, Tuba; Melekoglu, Rauf
    Microbial Chondroitin Sulfate (CS), possesses biocompatible, antiallergic, and non-toxic properties due to its polyanionic structure hold potential as an antifungal agent. This study investigated the effectiveness of microbial CS generated from recombinant Escherichia coli C2987 by biotechnological techniques as an antifungal product for treating Candida infections. Chondroitin biosynthesis was conducted utilizing a recombinant non-pathogenic E. coli, generated through the transformation of plasmid pETM6-PACF-vgb, which carries genes (kfoA, kfoC, and kfoF) responsible for chondroitin synthesis, along with the Vitreoscilla hemoglobin gene (vgb). The broth microdilution and agar dilution assays were employed to assess the antifungal activity of microbial CS and commercial CS against predominant Candida strains comparatively. The inhibitory effect of microbial CS against Candida albicans, Candida tropicalis, Candida parapsilosis, , and Candida krusei was greater than that of commercial CS. This study demonstrates the antifungal activity of microbial CS, a pharmacological agent produced from a recombinant source (vegan-halal). Microbial CS can be a potential supportive treatment not only for vaginal candidiasis but also for other Candida infections that may cause skin and mucosal infections, with its supportive effect on connective tissues and its therapeutic-preventive effect on possible Candida infections.
  • Küçük Resim Yok
    Öğe
    BIOCHEMICAL EFFECT EVALUATION OF MICROBIAL CHONDROITIN SULPHATE IN EXPERIMENTAL KNEE OSTEOARTHRITIS MODEL
    (Parlar Scientific Publications (P S P), 2022) Erenler, Ayse Sebnem; Karabulut, Aysun Bay; Sevimli, Resit; Geckil, Hikmet; Akpolat, Nusret; Unver, Tuba; Otlu, Onder
    Osteoarthritis (OA) is the most common chronic joint disease, primarily due to aging. Chondroitin sulfate (CS) is a glycosaminoglycan (GAG) commonly used to treat osteoarthritis. CS can delay the progression of pathology or reverse morphological changes in joint structure. Traditionally CS is produced from animal sources. However, due to different reasons such as contamination, ecological risk, and the possibility of infectious diseases, the trend towards microbial sources has increased because of its advantages such as purer, more antiallergic, and lower Molecular Weight (MW) than animal sources. Biochemical analysis of Microbial CS (MCS), which is a new and significant alternative as a source of CS in the OA healing process, has not been evaluated in the literature yet. This study was designed to analyze the biochemical effects of MCS produced by our team from a microbial source, with an MW value of 269 Daltons, on the osteoarthritis healing process compared to the commercial foiut. We aim to reach data that MCS has a higher antioxidant effect than animal -sourced CS, and in this way, it is a more suitable production for the treatment of osteoarthritis. In this study, knee osteoarthritis was surgically induced in experimental rabbits; and TGF113, CAT, MPO, TOS, and OSI parameters measured in blood samples before the operation and after the healing period were analyzed comparatively. After the surgical application, the rabbits were randomly divided into three groups: control, animal -sourced CS, and E. cull sourced. MCS. The standard rabbit diet was administered daily to 10 rabbits in Group 1 (control), and. CS and MCS were applied daily to the other groups as 17 mg/kg for 12 weeks. Blood samples were taken from rabbits at the 12th week after surgery, and TGF-113, CAT, MPO, TOS, and OSI parameters were biochemically evaluated. This study has confirmed that the antioxidant properties of MCS and data on its effectiveness in controlling oxidative stress compared to animal -sourced CS. Based on these results, it can be concluded that MCS has a significant potency of nutraceutical and therapeutic agents for OA treatment.
  • Küçük Resim Yok
    Öğe
    Comparative Analysis of Antioxidant, Anticholinesterase, and Antibacterial Activity of Microbial Chondroitin Sulfate and Commercial Chondroitin Sulfate
    (Wiley-V C H Verlag Gmbh, 2023) Unver, Tuba; Erenler, Ayse Sebnem; Bingul, Murat; Boga, Mehmet
    Chondroitin synthesis was performed using the recombinant Escherichia coli(C2987) strain created by transforming the plasmid pETM6-PACF-vgb, which carries the genes responsible for chondroitin synthesis, kfoA, kfoC, kfoF, and the Vitreoscilla hemoglobin gene (vgb). Then, Microbial chondroitin sulfate (MCS)'s antioxidant, anticholinesterase, and antibacterial activity were compared with commercial chondroitin sulfate (CCS). The antioxidant studies revealed that the MCS and CCS samples could be potential targets for scavenging radicals and cupric ion reduction. MCS demonstrated better antioxidant properties in the ABTS assay with the IC50 value of 0.66 mg than CCS. MCS showed 2.5-fold for DPPH and almost 5-fold for ABTS(center dot)+ (with a value of 3.85 mg/mL) better activity than the CCS. However, the compounds were not active for cholinesterase enzyme inhibitions. In the antibacterial assay, the Minimum inhibitory concentration (MIC) values of MCS against S. aureus, E. aerogenes, E. coli, P. aeruginosa, and K. pneumoniae (0.12, 0.18, 0.12, 0.18, and 0.18 g/mL, respectively) were found to be greater than that of CCS (0.42, 0.48, 0.36, 0.36, and 0.36 g/mL, respectively). This study demonstrates that MCS is a potent pharmacological agent due to its physicochemical properties, and its usability as a therapeutic-preventive agent will shed light on future studies.
  • Küçük Resim Yok
    Öğe
    Comparative evaluation of cytotoxic and anti-metastatic function of microbial chondroitin sulfate and animal-originated commercial chondroitin sulfate in cancer cells
    (C M B Assoc, 2023) Unver, Tuba; Celik-Uzuner, Selcen; Erenler, Ayse Sebnem
    Cancer has the second-highest mortality rate worldwide after cardiovascular disease. In addition, cervical and breast cancer are two of the leading causes of cancer-related deaths among women. The tumor microenvironment, which consists of cells that form blood vessels, proteins, fibroblasts, and immune cells, is a therapeutic target for cancer therapy. As part of the extracellular matrix (ECM), glycosaminoglycan Chondroitin Sulfate (CS) is related to diverse aspects of tumor growth and metastasis depending on the CS sulfate pattern. This study analyzed the roles of Microbial CS and Commercial CS in tumor growth and metastasis using HeLa cervical cancer cells, MDA-MB-231 metastatic breast cancer cells, and normal fibroblasts. In addition, the role of CS types in wound healing was also assessed comparatively. Microbial CS was more cytotoxic in MDA-MB-231 cells than HeLa compared to Commercial CS. Although both CS reduced cell viability in normal cells, the selective index of Microbial CS in MDA-MB-213 cells was higher than its commercial counterpart. In addition, the role of CS types in wound healing was also assessed comparatively. Both types of CS decreased the cell migration in MDA-MB-231 breast cancer cells, but HeLa cells were more sensitive to Microbial CS than Commercial CS to heal the wound. The wound healing of NIH3T3 cells after Microbial CS was similarly high to the healing after Commercial CS. This preliminary study shows that microbial CS produced by biotechnological methods from a recombinant source created by our team can be an effective therapeutic agent in various types of cancer.
  • Küçük Resim Yok
    Öğe
    Development of microbial chondroitin sulfate-based proton exchange membranes for microbial fuel cells
    (Elsevier Sci Ltd, 2024) Erenler, Sebnem A.; Unver, Tuba; Ozaslan, Bahar F.; Koytepe, Suleyman; Sezer, Selda
    Technological developments have led to a significant increase in energy demand, and thus the interest in alternative energy has increased in the same direction. For this reason, fossil fuel reserves and climate-based renewable energy sources were used as alternatives in energy production, but the desired success was not fully achieved due to the decrease in fossil fuel and climate changes, and a new alternative energy source was sought. This situation has made Microbial Fuel Cells (MFC), which can directly convert chemical energy, an important alternative to renewable energy, from organic waste into electrical energy with the help of microorganisms. Therefore, in this study, microbially obtainable chondroitin, which is a non-toxic, biocompatible organic molecule that will not disrupt the ecological balance, sulfate-based proton exchange membrane was prepared for the microbial fuel cell. For this, Chondroitin was synthesized by the microbial method, chondroitin sulfate was obtained by sulfation, and chondroitin sulfate membranes were prepared by cross-linking with sulfosuccinic acid at varying molar concentrations (0.2, 0.4, 0.6, and 0.8). Firstly, the structural characterization, thermal properties, and morphological features of the prepared 20 mm thickness membranes were investigated, and then the effects of parameters such as pH change, voltage, quaternization, internal resistance, and coulomb efficiency on microbial fuel cell performance were studied. The best result was found to be that of chondroitin sulfate cross-linked with 0.8 M sulfosuccinic acid, which had an internal resistance of 0.310 omega, a power density of 30 mW/m2, and a coulomb efficiency of 70 %. Additionally, proton conductivity was measured to be 0.9919 mS/ cm, and thanks to the proton conduction efficiency of the designed Microbial chondroitin sulfate membranes, it has been determined that it has an effective proton exchange membrane potential. These developments show that microbial chondroitin sulfate-based membranes may be an alternative candidate for microbial fuel cells.
  • Küçük Resim Yok
    Öğe
    Effect of vgb gene on microbial chondroitin sulfate production in recombinant Escherichia coli pETM6-PACF-vgb and physicochemical characterization of produced chondroitin sulfate
    (Cellular and Molecular Biology Association, 2025) Erenler, Ayse Sebnem; Unver, Tuba; Ceylan, Ahmet Faruk; Ozcan, Imren; Geckil, Hikmet
    Chondroitin Sulfate (CS) is an essential component of the extracellular matrix and is a sulfated glycosaminoglycan structurally composed of a polysaccharide chain consisting of N-acetyl galactosamine and glucuronic acid. The use of CS of animal origin is common in pharmacological research. The disadvantages of traditional sources and methods used in the production of CS, which is used in various applications in the medicine, veterinary, pharmacy, and cosmetic sectors, have made microbial production a vital alternative. In this study, recombinant Escherichia coli (pETM6-PACF-vgb) strain, in which kfoA, kfoC, kfoF and vgb gene regions are co-expressed, and E. coli pETM6-PACF strain, which does not contain the vgb gene, were used in the microbial production of CS. The vgb gene is the region responsible for expressing the bacterial protein Vitreoscilla hemoglobin (VtHb). This study investigated the effect of the expression of VtHb in E. coli on increasing bacterial cell respiration and, therefore, how ATP production would affect cell growth and the acquisition of chondroitin and microbial chondroitin sulfate (MCS) from biomass. The analysis results determined a 23.07% increase in the amount of MCS produced from the vgb+ strain. The presence of vgb had positively affected culture age and reproductive kinetics. Spectrophotometric measurements, NMR, HPLC, FT-IR, TGA, DTA, and DSC analyses for the reproductive values and physicochemical characterization of the obtained MCS were applied to discuss this production process. For more detailed results on this subject, future research focused on optimization is needed. © 2025 Cellular and Molecular Biology Association. All rights reserved.

| Malatya Turgut Özal Üniversitesi | Kütüphane | Açık Bilim Politikası | Açık Erişim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


Malatya Turgut Özal Üniversitesi, Malatya, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2026 LYRASIS

  • Çerez Ayarları
  • Gizlilik Politikası
  • Son Kullanıcı Sözleşmesi
  • Geri Bildirim